RMD vs. CBOE
RMD (ResMed Inc.) and CBOE (Cboe Global Markets, Inc.) are both stocks. RMD operates in Medical Instruments & Supplies (Healthcare), while CBOE operates in Financial Data & Stock Exchanges (Financial Services). Over the past 10 years, RMD returned 13.71%/yr vs 17.38%/yr for CBOE. At a 0.21 correlation, their price movements are largely independent.
Performance
RMD vs. CBOE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RMD achieves a -19.39% return, which is significantly lower than CBOE's 12.19% return. Over the past 10 years, RMD has underperformed CBOE with an annualized return of 13.71%, while CBOE has yielded a comparatively higher 17.38% annualized return.
RMD
- 1D
- -1.48%
- 1M
- -6.31%
- YTD
- -19.39%
- 6M
- -22.35%
- 1Y
- -22.67%
- 3Y*
- -2.34%
- 5Y*
- -0.97%
- 10Y*
- 13.71%
CBOE
- 1D
- -0.56%
- 1M
- -19.41%
- YTD
- 12.19%
- 6M
- 11.21%
- 1Y
- 27.25%
- 3Y*
- 27.99%
- 5Y*
- 21.30%
- 10Y*
- 17.38%
RMD vs. CBOE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | -19.39% | 6.26% | 34.18% | -16.55% | -19.47% | 23.41% | 38.33% | 37.85% | 36.38% | 39.06% |
CBOE Cboe Global Markets, Inc. | 12.19% | 29.96% | 10.74% | 44.37% | -2.16% | 42.23% | -21.17% | 24.16% | -20.60% | 70.49% |
Correlation
The correlation between RMD and CBOE is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2010 | 0.21 |
The correlation between RMD and CBOE shifts across timeframes, from 0.03 (3 years) to 0.21 (all time), reflecting how their relationship changes across market environments.
Fundamentals
RMD:
$13.78
CBOE:
$11.77
RMD:
14.02
CBOE:
23.83
RMD:
0.43
CBOE:
0.44
RMD:
3.85
CBOE:
6.14
RMD:
$5.54B
CBOE:
$4.79B
RMD:
$3.42B
CBOE:
$2.50B
RMD:
$2.10B
CBOE:
$1.87B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RMD vs. CBOE — Risk / Return Rank
RMD
CBOE
RMD vs. CBOE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and Cboe Global Markets, Inc. (CBOE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RMD | CBOE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.97 | ||
| Sortino ratioReturn per unit of downside risk | -2.69 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.20 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | 1.11 | -1.72 |
| Martin ratioReturn relative to average drawdown | -1.42 | 5.44 | -6.86 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RMD | CBOE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.95 | 1.01 | -1.97 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | 0.92 | -0.96 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.69 | -0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.66 | -0.14 |
Drawdowns
RMD vs. CBOE - Drawdown Comparison
The maximum RMD drawdown since its inception was -61.61%, which is greater than CBOE's maximum drawdown of -43.23%. Use the drawdown chart below to compare losses from any high point for RMD and CBOE.
Loading charts...
Drawdown Indicators
| RMD | CBOE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.61% | -43.23% | -18.38% |
Max Drawdown (1Y)Largest decline over 1 year | -37.28% | -24.69% | -12.59% |
Max Drawdown (3Y)Largest decline over 3 years | -40.09% | -24.69% | -15.40% |
Max Drawdown (5Y)Largest decline over 5 years | -53.99% | -24.69% | -29.30% |
Max Drawdown (10Y)Largest decline over 10 years | -53.99% | -43.23% | -10.76% |
Current DrawdownCurrent decline from peak | -33.74% | -23.40% | -10.34% |
Average DrawdownAverage peak-to-trough decline | -15.98% | -11.40% | -4.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.95% | 5.02% | +10.93% |
Volatility
RMD vs. CBOE - Volatility Comparison
The current volatility for ResMed Inc. (RMD) is 10.44%, while Cboe Global Markets, Inc. (CBOE) has a volatility of 15.60%. This indicates that RMD experiences smaller price fluctuations and is considered to be less risky than CBOE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RMD | CBOE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.44% | 15.60% | -5.16% |
Volatility (6M)Calculated over the trailing 6-month period | 19.50% | 23.74% | -4.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.97% | 27.02% | -3.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.12% | 23.17% | +7.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.55% | 25.32% | +6.23% |
Dividends
RMD vs. CBOE - Dividend Comparison
RMD's dividend yield for the trailing twelve months is around 1.24%, more than CBOE's 1.03% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CBOE Cboe Global Markets, Inc. | 1.03% | 1.08% | 1.21% | 1.18% | 1.56% | 1.38% | 1.68% | 1.12% | 1.19% | 0.83% | 1.30% | 1.36% |
RMD ResMed Inc. | 1.24% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Financials
RMD vs. CBOE - Financials Comparison
This section allows you to compare key financial metrics between ResMed Inc. and Cboe Global Markets, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RMD vs. CBOE - Profitability Comparison
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.
CBOE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cboe Global Markets, Inc. reported a gross profit of 669.90M and revenue of 1.27B. Therefore, the gross margin over that period was 52.6%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.
CBOE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cboe Global Markets, Inc. reported an operating income of 505.60M and revenue of 1.27B, resulting in an operating margin of 39.7%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.
CBOE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cboe Global Markets, Inc. reported a net income of 385.70M and revenue of 1.27B, resulting in a net margin of 30.3%.
Frequently Asked Questions
RMD and CBOE have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CBOE has higher volatility (15.60%) compared to RMD (10.44%). In terms of maximum drawdown, RMD dropped -61.61% vs CBOE's -43.23%.
CBOE currently has the higher Sharpe Ratio (1.01 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RMD and CBOE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer